# Garwood Medical Devices

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/garwood-medical-devices

- Industry: Medical Devices & Equipment
- Headquarters: Buffalo, US
- Website: www.garwoodmedicaldevices.com/
- Total disclosed funding: $4M
- Latest round: Series C (Aug 20, 2020)
- Investors on record: 2

## About

Founded in 2014 and based in New York, US, Garwood Medical Devices, LLC is a developer of medical devices that provides treatments for chronic wound healing, bone growth, and peri-prosthetic infection. In January 2024, Garwood Medical Devices, LLC raised venture funding from Teijin. As of 2024, the company is led by its CEO and president, Wayne Bacon.

The company focuses on advancing implant infection control with its product, BioPrax™. As of July 2024, this device is under investigation and eliminates bacterial biofilm infections on prosthetic knee implants during early intervention procedures. BioPrax™ eliminates biofilms, including drug-resistant bacteria like MRSA and E. coli. The system uses a minimally invasive procedure involving low voltage energy to target and clear biofilms from implant surfaces, improving patient outcomes and implant retention.

The organization plans to use the January 2024 funding to support ongoing research and development in healthcare technology.

## Funding rounds

- Series C, Aug 20, 2020, $4M — WNY Impact Investment Fund, Murray Capital

## Investors

- WNY Impact Investment Fund (https://capitalatlas.ai/funds/wny-impact-investment-fund) — Series C
- Murray Capital (https://capitalatlas.ai/funds/murray-capital) — Series C